X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Divis Laboratories - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs DIVIS LABORATORIES - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD DIVIS LABORATORIES MERCK LTD/
DIVIS LABORATORIES
 
P/E (TTM) x 34.2 31.3 109.1% View Chart
P/BV x 3.8 5.4 70.5% View Chart
Dividend Yield % 0.7 0.9 81.0%  

Financials

 MERCK LTD   DIVIS LABORATORIES
EQUITY SHARE DATA
    MERCK LTD
Dec-16
DIVIS LABORATORIES
Mar-17
MERCK LTD/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,0601,222 86.7%   
Low Rs623784 79.5%   
Sales per share (Unadj.) Rs632.4153.1 413.1%  
Earnings per share (Unadj.) Rs45.739.9 114.4%  
Cash flow per share (Unadj.) Rs62.344.6 139.7%  
Dividends per share (Unadj.) Rs11.0010.00 110.0%  
Dividend yield (eoy) %1.31.0 131.1%  
Book value per share (Unadj.) Rs388.8201.8 192.7%  
Shares outstanding (eoy) m16.60265.47 6.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.36.6 20.3%   
Avg P/E ratio x18.425.1 73.3%  
P/CF ratio (eoy) x13.522.5 60.0%  
Price / Book Value ratio x2.25.0 43.5%  
Dividend payout %24.125.0 96.1%   
Avg Mkt Cap Rs m13,969266,266 5.2%   
No. of employees `0001.69.7 16.3%   
Total wages/salary Rs m1,4874,687 31.7%   
Avg. sales/employee Rs Th6,631.94,175.0 158.8%   
Avg. wages/employee Rs Th939.2481.5 195.1%   
Avg. net profit/employee Rs Th479.41,089.3 44.0%   
INCOME DATA
Net Sales Rs m10,49840,643 25.8%  
Other income Rs m242749 32.4%   
Total revenues Rs m10,74141,392 25.9%   
Gross profit Rs m1,13514,460 7.9%  
Depreciation Rs m2761,233 22.3%   
Interest Rs m023 0.0%   
Profit before tax Rs m1,10213,953 7.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3433,349 10.3%   
Profit after tax Rs m75910,604 7.2%  
Gross profit margin %10.835.6 30.4%  
Effective tax rate %31.124.0 129.8%   
Net profit margin %7.226.1 27.7%  
BALANCE SHEET DATA
Current assets Rs m6,41040,105 16.0%   
Current liabilities Rs m8,8286,595 133.9%   
Net working cap to sales %-23.082.5 -27.9%  
Current ratio x0.76.1 11.9%  
Inventory Days Days58119 48.7%  
Debtors Days Days3881 47.6%  
Net fixed assets Rs m1,40619,995 7.0%   
Share capital Rs m166531 31.3%   
"Free" reserves Rs m6,28653,043 11.9%   
Net worth Rs m6,45553,574 12.0%   
Long term debt Rs m00-   
Total assets Rs m8,82861,585 14.3%  
Interest coverage xNM618.4-  
Debt to equity ratio x00-  
Sales to assets ratio x1.20.7 180.2%   
Return on assets %8.617.3 49.8%  
Return on equity %11.819.8 59.4%  
Return on capital %17.126.1 65.5%  
Exports to sales %8.30-   
Imports to sales %21.025.2 83.4%   
Exports (fob) Rs m869NA-   
Imports (cif) Rs m2,20910,259 21.5%   
Fx inflow Rs m95935,384 2.7%   
Fx outflow Rs m2,61210,399 25.1%   
Net fx Rs m-1,65324,985 -6.6%   
CASH FLOW
From Operations Rs m1,07011,493 9.3%  
From Investments Rs m-750-11,372 6.6%  
From Financial Activity Rs m-150-93 160.9%  
Net Cashflow Rs m17128 601.8%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 11.8 154.2%  
FIIs % 1.0 19.0 5.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 17.2 169.2%  
Shareholders   28,591 31,796 89.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   TORRENT PHARMA  ALKEM LABORATORIES  AJANTA PHARMA  SANOFI INDIA  ALEMBIC PHARMA  

Compare MERCK LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Jan 19, 2018 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD 8-QTR ANALYSIS

COMPARE MERCK LTD WITH

MARKET STATS